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Abstract
The blood-brain barrier (BBB) is formed in part by vascular endothelial cells that constitute the 
capillaries and microvessels of the brain. The function of this barrier is to maintain homeostasis 
within the brain microenvironment and buffer the brain from changes in the periphery. A 
dysfunction of the BBB would permit circulating molecules and pathogens typically restricted to 
the periphery to enter the brain and interfere with normal brain function. As increased 
permeability of the BBB is associated with several neuropathologies, it is important to have a 
reliable and sensitive method that determines BBB permeability and the degree of BBB disruption. 
A detailed protocol is presented for assessing the integrity of the BBB by transcardial perfusion of 
a 10,000 Da FITC labeled dextran molecule and its visualization to determine the degree of 
extravasation from brain microvessels.
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INTRODUCTION
The brain has a network of capillaries that delivers nutrients and oxygen and removes waste 
products generated by neurons and glia (Abbott et al., 2006). This neurovascular unit 
includes capillaries that are composed of tightly aligned vascular endothelial cells that 
strictly regulate the entrance of large hydrophilic molecules into the brain. The 
physicochemical barrier that is formed is referred to as the blood-brain barrier (BBB) 
(Risau, 1996). Many disease conditions including stroke, epilepsy, Multiple Sclerosis, 
Alzheimer’s disease, human immunodeficiency virus, traumatic brain injury, and drug abuse 
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damage the BBB (Chodobski et al., 2011; Dallasta et al., 1999; Marchi et al., 2012; Marques 
et al., 2013; Minagar and Alexander, 2003; Northrop and Yamamoto, 2015; Sandoval and 
Witt, 2008). Therefore, a reliable method is needed to study whether and to what extent the 
BBB is permeable in order to determine the degree of disruption and to devise appropriate 
therapeutic strategies.
Agents such as Evans Blue, albumin, horseradish peroxidase (HRP), immunoglobulin (IgG), 
radioactive tracers, sodium fluorescein and dextran have been typically employed to assess 
BBB permeability (Saunders et al., 2015). The choice of the appropriate molecule is 
important when assessing BBB permeability such that a good marker of BBB integrity 
should be inert and without any effect on the physiology and function of the animal. 
Additionally, the marker should be large enough to remain in healthy brain capillaries and be 
able to freely diffuse out of compromised blood vessels. Evans Blue relies on its conjugation 
with albumin to form a large molecule. The drawback is that smaller unbound Evans Blue 
molecules can still diffuse out of intact capillaries and enter the brain parenchyma without 
significant increases in BBB permeability, leading to false positive conclusions. IgG is a 
very large molecule and may not reveal subtle disruptions in the BBB. In addition, since IgG 
and similarly, albumin is endogenous to the body and present in the blood at all times, the 
exact onset of BBB disruption would not be apparent by measuring IgG or albumin in the 
brain. Thus, it is important to use different markers that can reliably assess variations in 
timing and permeability of the BBB as the opening of the BBB is not an all or none 
phenomenon, can occur in a graded manner, and can be the cause or the consequence of 
another event.
One marker is fluorescein isothiocyanate (FITC) labeled dextrans. FITC-dextrans are 
polysaccharides comprised of varying lengths of branched glucose molecules (Hoffmann et 
al., 2011). These molecules are commercially available in molecular weights ranging from 4 
– 70 kDa and can be used to determine solute, ion and protein permeability of the BBB 
based on the size of the dextran used. Because FITC-dextrans are exogenous and can be 
administered at discrete intervals, in contrast to endogenous molecules like IgG and 
albumin, they can provide valuable information on the time course and duration of BBB 
permeabilization. An added benefit of FITC-dextran is that low brain concentrations of 
fluorescein can be measured due to the high sensitivity of fluorescence detection and its 
negligible binding to plasma proteins (Wolman, 1981).
BASIC PROTOCOL 1: Assessment of FITC-dextran extravasation from the 
BBB
The protocol below details the methodology for perfusing 10,000 Da FITC-dextran in 
anesthetized Sprague-Dawley rats to assess BBB integrity. While Sprague-Dawley rats were 
used, this procedure could be adapted for other rodents, and possibly other non-primates, if 
body weight is accounted for. Once FITC-dextran has been perfused it fills brain capillaries 
and can be observed using a fluorescence microscope or under excitation by the 488 laser. 
The brain capillaries and surrounding parenchyma with FITC-dextran can then be imaged 
and analyzed to assess BBB integrity.
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All experiments were conducted in accordance to National Institute of Health Guide for 
Care and Use of Laboratory Animals and approved by Indiana University Institutional 
Animal Care and Use Committee.
Materials
• 0.1M and 0.2M Phosphate Buffered Saline (PBS) (see recipe)
• 4% paraformaldehyde (PFA) solution (see recipe)
• 10% and 20% Glycerol solution (see recipe)
• FITC-dextran solution (see recipe)
• Gelatin subbing solution (see recipe)
• Brain freezing solution (see recipe)
• Millipore™ water
• 250–300 g Sprague-Dawley rats (Harlan, RRID:RGD_10395233)
• Ketamine
• Xylazine (Butler Schein cat. no. 33197)
• Heparin
• 26 G needle (Fisher scientific, cat. no. 14-826-10)
• 16 G11/2 needle (Fisher scientific, cat. no. 14-821-14H)
• 1 mL syringe (Fisher scientific, cat. no. 14-823-434)
• Perfusion pump (Fisher scientific, cat. no. 13-876-2)
• Blunt scissors (Fisher scientific, cat. no. 08-950)
• Micro dissection scissors (Fisher scientific, cat. no. 08-935)
• Hemostat (Fisher scientific, cat. no. 16-100-118)
• Bone rongeurs (Fisher scientific, cat. no. NC0688492)
• Guillotine (Harvard Instruments cat. no. 55-0020)
• Spatula (Fisher scientific, cat. no. S50823)
• Glass beaker (Fisher scientific, cat. no 02-540K, 02-540T))
• Graduated cylinder (Fisher scientific, cat no. 03-007-45)
• Filtering apparatus (Duran cat. no. 2134031)
• Filter paper (Sigma cat. no.58060-U)
• Stir bar (Fisher scientific, cat. no. 14-513-51)
• Cryostat (Fisher scientific, Cryostar NX50)
• Pedestals (Fisher scientific, cat. no. 715870-CN)
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• TissueTek (Electron microscopy sciences, cat. no. 62550-12)
• Glass slides (Worldwide medical, cat. no. 48011066)
• Slide racks (Wheaton, cat.no. 900254)
• Coverslip (Fisher scientific, cat.no. 12-545-100)
• Slide box (Fisher scientific, cat.no. 03-446)
• Small sample jars (Weaton, cat.no. W216971)
• Fluoromount-G (Electron microscopy sciences, cat. no. 17984-25)
• Ice bucket (Fisher scientific, cat. no. 07-210-129)
• DRAQ5 (Cell signaling, cat.no. 4054S, RRID:AB_2314341)
• Hot plate (Fisher scientific, cat.no. 11-497-6A)
• Confocal microscope with 488, 633 excitation laser
• Image J software (http://rsb.info.nih.gov/ij/index.html, RRID:SCR_003070)
• Microfiber cloth
• Aluminum foil
• Slide rack (EMS, cat.no. 71394-01)
• Deep tray for submerging slide rack (12″L X 6″W X 2″D)
• Dry ice
• Oven (Norco Model 410)
• Access to sink and water
Protocol steps—Step annotations
Perfusion pump set-up
1. Carry out the perfusion under low light conditions to minimize quenching of 
fluorescence of the FITC-dextran solution.
2. Assemble all the tools required for perfusion surgery (Figure 1A).
3. Place the perfusion pump at a higher elevation than the rat to be perfused (Figure 
1B). This perfusion does not need to be performed in a fume hood since FITC 
dextran is not hazardous.
4. Fill a 50 mL graduated cylinder with FITC-dextran solution wrapped in foil to 
block exposure to light and prevent any decrease or quenching of fluorescence. 
Once you begin perfusion, unwrap the cylinder just enough so you can see the 
graduation marks on the cylinder.
5. Place the inflow tubing (Tygon, I.D. 1/8, O.D. 1/4, wall 1/16) of the pump into 
the FITC solution in the beaker and fit the other end of the tubing with a 16 G 
needle.
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6. Start the pump to fill the tubing with FITC-dextran solution. Adjust the pump 
setting so that the flow rate is 12 mL per minute.
7. Dislodge any air bubbles that form along the lines by flicking the tubing, so that 
they float to the top and can be eliminated at the other end of the line.
8. Stop the pump immediately when FITC emerges from the 16 G needle. It is 
important not to have any air bubbles in the lines as they can rupture capillaries 
and cause false positive extravasation or poor perfusion of the solution.
Perfusion Surgery
1. Inject ketamine (75 mg/kg) and xylazine (5 mg/kg) intraperitoneally into the rat.
2. Pinch the paw to test for absence of paw retraction and ensure that the rat has 
reached a surgical plane of anesthesia prior to starting the perfusion surgery.
3. Place the rat on a grate over a sink. Turn the water faucet on to help drain the 
blood that will collect in the sink. The MSDS for FITC-dextran indicates that it 
is a non-hazardous substance that does not require special disposal procedure.
4. Lift the skin over the ribs using a hemostat, and make a 1 cm cut using a blunt 
scissors through the abdominal wall under the rib cage.
5. Insert the blunt side of the scissors into the abdominal opening and carefully cut 
up to the sides of the ribs being careful not to make any cuts or nicks in the liver.
6. Grab the exposed sternum with the hemostat and cut the tissue connecting the 
liver to the sternum.
7. Make a small incision in the diaphragm and carefully insert the blunt end of the 
scissors and continue to cut along the entire length to expose the pleural cavity.
8. Using the blunt scissors, cut along one side of the ribs up to the collarbone on 
both sides, while being careful not to cut or nick the lungs.
9. Lift up the sternum and cut the tissue connecting the heart to the ribs. Make sure 
that the heart is fully exposed with clear access to the atria and ventricles.
10. Inject heparin (0.35 cc) into the posterior end of the left ventricle and wait 1 min 
before inserting the 16 G needle, ideally, in the same hole as the heparin injection 
(Figure 1C).
11. Prior to turning on the pump, make note of how much FITC dextran solution is 
in the 50 mL graduated cylinder. This will be important as you will want to stop 
the pump when 12 mL has been used.
12. Turn on the pump and use a small dissecting scissors to make an incision, 
approximately 5–8 mm, through the right atrium.
13. Make the incision large enough for the blood to leak freely without pulsing.
14. Perfuse 12 mL of FITC-dextran solution at the rate of 12 mL per minute.
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15. Turn off the pump once 12 mL of the FITC-dextran has been perfused through 
the rat (Figure 1D) and remove the needle from the rat’s heart.
16. Immediately after perfusion is complete, decapitate the rat using a guillotine.
Brain Removal
1. Remove the skull overlying the brain using a 5.5 inch bone rongeurs (Figure 1E).
2. Carefully use scissors to cut any dura, nerves, or connective tissue
3. Insert a spatula along the side of the skull and tease the brain away from the 
cranium.
4. Place the brain in a small sample jar filled with 4% PFA and keep at 4°C.
Fixation and Cryoprotection
1. Keep the brain protected from light from this point onwards by wrapping the 
sample jar in foil and incubate at 4°C for 3 days.
2. After 3 days discard the PFA in the jar and gently rinse the jar and brain with 
cold 10% glycerol solution.
3. Fill the jar with cold (4°C) 10% glycerol solution and incubate the brain in the 
10% glycerol solution for 18–24 hours at 4°C.
4. The following day discard the 10% glycerol solution and rinse the jar and brain 
with cold 20% glycerol solution.
5. Fill the jar with cold (4°C) 20% glycerol solution and incubate the brain in 20% 
glycerol solution for 18–24 hours at 4°C.
Flash-Freeze Brains—Brains should then be flash frozen by immersing in cooled 2-
methylbutane for 5 min.
Flash-freezing using 2-methylbutane
1. Fill a small 25 mL beaker with 2-methylbutane.
2. Place the beaker in an ice bucket containing a layer of dry ice on the bottom. 
Surround the beaker with more dry ice.
3. Fill the ice bucket with 95% ethanol so that the dry ice is saturated with ethanol. 
Avoid introducing dry ice or ethanol into the 2-methylbutane solution and 
contaminating it.
4. Allow this setup to cool the 2-methylbutane for approximately 3 hrs.
5. Test to see if the 2-methylbutane solution has cooled sufficiently by placing a 
small piece of brain (1cm3) into the 2-methylbutane solution using a tweezer. If 
the piece of brain hardens in 5 sec, then the solution is ready for flash freezing a 
whole brain. This test can be done using a piece of brain tissue that will not be 
studied in the current experiment.
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6. Immerse the brain in 2-methylbutane for at least 1 min but no longer than 5 
minutes.
Preparing slides for mounting brain tissue
Subbing slides
1. Place slides in slide holder and soak in tray containing 0.1N hydrochloric acid 
for 1hr. The number of slides to sub should be based on the experimental design 
and rostro-caudal extent of the brain region of interest.
2. Remove 0.1N hydrochloric acid and rinse in distilled water 3 times for 30 
seconds.
3. Soak in 95% ethanol for 1hr to overnight.
4. Remove ethanol and let slides dry completely.
5. Add gelatin subbing solution to the tray.
6. Immerse slides into the gelatin solution for 2 min.
7. Remove slides and place in 80°C oven for 15 min.
8. Take out slides from oven and allow to cool down for 15 min.
9. Repeat steps 6–8 an additional 3 times.
10. Once slides are completely dry, place them in slide boxes and store in −20°C for 
long term storage.
Sectioning the brain using the cryostat
1. Maintain the cryostat temperature around −20 to −23°C and keep the cryostat 
lights off and the room lights dim.
2. Add 1 drop of TissueTek or similar mounting medium to the center of the 
pedestal and place brain on the TissueTek/mounting medium oriented for the 
appropriate type section.
3. Add finely powdered dry ice around the brain to freeze the TissueTek/mounting 
medium.
4. Place pedestal with the brain in the ice bucket and cover brain completely with 
finely powdered dry ice for 2 min
5. Remove the pedestal containing the brain from the dry ice and apply additional 
TissuTek/mounting medium around the brain and allow it to set for an additional 
2 min.
6. Place the pedestal in the cryostat for at least 2hr to equilibrate with the cryostat 
chamber temperature before sectioning.
7. Use the cryostat trim setting to advance to the area of interest.
8. Switch from trim to fine setting and set the section thickness to 50 μm and 
collect the slices.
Natarajan et al. Page 7
Curr Protoc Neurosci. Author manuscript; available in PMC 2018 April 10.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
9. Place a drop of Millipore™ water onto the subbed slide and use a soft bristled 
paint brush to pick up the tissue section from the blade and place it on the drop 
of water. The section should unroll or unfold with little effort.
10. Use the paint brush gently and sparingly to help align and orient the section 
without disrupting or tearing the tissue.
11. Use a Kimwipe® to absorb the water and lay the section flat on the subbed glass 
slide.
12. Mount up to 3 sections per slide without disrupting previously mounted sections 
on the slide.
13. Allow sections to air dry completely.
14. Place slides in slide boxes and store at −20°C at this point prior to imaging.
Prepping slides prior to imaging
1. Remove slide from −20°C and immerse in DRAQ5 nuclear stain for 5 min. This 
step allows for setting the focal plane of the tissue during confocal imaging prior 
to visualizing fluorescence of FITC- dextran.
2. While the tissue is still wet, apply a line of Fluoromount-G mounting media over 
each of the 3 tissue sections.
3. Place an appropriate thickness coverslip (based on penetration capability of the 
objective in the confocal microscope) at one end of the slide and carefully lower 
it to the other end avoiding the capture of air bubbles.
4. If air bubbles get trapped between cover glass and tissue section, gently press on 
the cover glass and move the bubble out of the tissue towards the edge.
5. Allow for Fluoromount-G to set overnight at room temperature, in the dark, 
before imaging.
6. The next day remove any smudges or Fluoromount-G overflow on the slide by 
wiping with a soft microfiber cloth dipped in 70% ethanol.
Confocal Imaging
1. Use an available confocal microscope to image FITC-dextran extravasation.
2. The necessary parameters for imaging is the availability of 633 nm excitation 
wavelength laser and an emission collection at 660/20 band pass filter for 
visualizing DRAQ5 nuclear stain for orienting the focal plane of the tissue.
3. FITC-dextran visualization requires a 488 nm excitation wavelength laser and an 
emission collection spectrum of 504–556 nm.
4. The images can be captured at 4 μm z steps.
5. Use the same Gain, Offset and exposure settings for all images captured within 
one experiment.
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6. Capture multiple images from the region of interest and from multiple brain 
sections of the same region.
Image J Software for data analysis
1. Use Image J for analyzing the data obtained from confocal imaging.
2. Download Image J software from https://imagej.nih.gov/ij/
3. Download the Bioformats plugin and install it in the plugins folder as detailed on 
the website. This plugin is important for opening different types of image 
formats.
REAGENTS AND SOLUTIONS
• 0.1M and 0.2M Phosphate Buffered Saline (PBS)
– Sodium chloride
– Monosodiumphosphate
– Disodiumphosphate
• 4% paraformaldehyde (PFA) solution
– 0.2M PBS
– 6N sodium hydroxide
– PFA
• 10% and 20% Glycerol solution
– 0.2M PBS
– Glycerol
– Dimethylsulfoxide
– Millipore™ water
• FITC dextran solution
– 10,000 Da FITC labeled dextran
– Cold 0.1M PBS
• Gelatin subbing solution
– Chromium potassium sulfate
– 0.1N hydrochloric acid
– 95% ethanol
– 70% ethanol
• Brain freezing solution
– 2-methylbutane
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– Dry ice
– 95% ethanol
• Access to Millipore water
0.1M Phosphate Buffered Saline (PBS)
To make 2L of 0.1M PBS:
Sodium chloride (NaCl) – 17.54 g
Monosodiumphosphate (NaH2PO4) – 0.36 g
Disodiumphosphate (Na2HPO4) – 2.48 g
Dissolve the above reagents in about 1800 mL of Millipore™ water, and then bring up the 
volume to 2 L using Millipore™ water. Store at 4°C.
0.2M Phosphate Buffered Saline (PBS)
To make 1L of 0.2M PBS:
Sodium chloride (NaCl) – 17.54 g
Monosodiumphosphate (NaH2PO4) – 0.36 g
Disodiumphosphate (Na2HPO4) – 2.48 g
Dissolve the above ingredients in about 800 mL Millipore™ water, and then bring up the 
volume to 1L using Millipore™ water. Store at 4°C.
4% Paraformaldehyde (PFA)
To make 2 L of 4% PFA:
1. Heat 1L of Millipore™ water to 95°C and add 80 g of PFA while maintaining 
temperature between 80–95°C.
2. Stir for 10 min, turn off heat and add a few drops of 6N NaOH until solution 
turns clear.
3. If the volume of the solution is less than 1L, due to evaporation, add Millipore 
water to bring the volume to 1L.
4. Add 1L of cold 0.2M PBS to the PFA solution and allow to cool to room 
temperature.
5. Check pH and adjust to 7.4 and filter solution.
6. Store solution at 4°C for up to 1 month.
10% Glycerol Solution
To make 700 mL solution
0.2M PBS – 350 mL
Glycerol – 70 mL
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Dimethylsulfoxide – 14 mL
Millipore™ water – 266 mL
Place a 1 L graduated cylinder on a stir plate and mix together the above solutions using a 
stir bar. Store at 4°C for up to 1 month.
20% Glycerol Solution
To make 700 mL solution:
0.2M PBS – 350 mL
Glycerol – 140 mL
Dimethylsulfoxide – 14 mL
Millipore™ water – 196 mL
Place a 1 L graduated cylinder on a stir plate and mix together the above solutions using a 
stir bar until a uniform solution is obtained. Store at 4°C for up to 1 month.
FITC-Dextran Solution
To make 100 mL solution (10 mg/mL):
10,000 Da FITC labeled dextran – 1 g
Cold 0.1M PBS pH 7.4 – 100 mL
Wrap 200 mL beaker in foil and solubilize above ingredients for 30 min to ensure that any 
clumps that may have formed have completely dissolved. This solution can be made up fresh 
and/or stored at 4°C for approximately 72 hrs before using it.
Gelatin Subbing Solution
To make 1600 mL subbing solution
Gelatin – 8.23 g
Chromium potassium sulfate – 0.8 g
1. Heat 1600 mL Millipore™ water to 60°C.
2. Add gelatin slowly into the water while stirring to avoid clumping.
3. Once completely dissolved add 0.8g chromium potassium sulfate to gelatin 
mixture.
4. Filter while hot.
5. Use this solution for subbing slides within 2 hrs of preparation.
COMMENTARY
Dye perfusion is often followed by a saline or PBS perfusion in order to visualize 
background extravasation in the absence of capillaries. However, the perfusion of the 
capillaries with PBS after FITC-dextran is not recommended to minimize the chance of 
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capillary rupture by the perfusion of PBS. Furthermore, image manipulations can be carried 
out as detailed in the Analysis section, to exclude the fluorescent capillaries without 
introducing the additional variable of PBS perfusion, which could contribute to false positive 
results. Additionally, it is possible that the subsequent PBS perfusion can leak out of 
permeabilized BBB and wash out the FITC-dextran in the surrounding brain parenchyma 
causing false negative results. Finally, FITC-dextran in the capillaries helps to visualize the 
density as well as the morphology of capillaries and acts as an indicator of successful 
perfusion in the animal (Figure 2) whereas the removal of the FITC-dextran precludes 
validation of the status of perfusion (Figure 3).
Confocal imaging is essential for assessing FITC-dextran extravasation and fluorescence 
quantification. Confocal imaging allows for collecting specific wavelengths of light emitted 
by FITC without including scattered light of other wavelengths that may not be specific to 
FITC. Additionally, the emission spectra can be obtained throughout the depth of the 3-
dimensional plane of a tissue section. Thus, the tissue section can be imaged for 
fluorescence throughout its entire thickness without confounds due to scattered light from 
one plane affecting fluorescence in another plane within the same tissue.
Post-imaging manipulations to exclude fluorescence in the capillaries removes fluorescence 
within the capillaries imaged throughout the depth of the tissue and permits the measure of 
fluorescence in the non-capillary parenchyma only. In this manner, fluorescence from FITC-
dextran filled capillaries through the thickness of the tissue section can be excluded (Figure 
4). This allows for visualization and quantification of the increased background fluorescence 
indicative of FITC that has diffused from the leaky capillaries and into the surrounding 
parenchyma. At the same time, it excludes FITC-dextran confined within capillaries that 
would otherwise contribute to background fluorescence.
Background Information
Dyes have been used for assessing the integrity of the BBB dating back to the end of the 19th 
century (Saunders et al., 2014). Dyes such as vital red and brilliant red were initially used to 
assess BBB permeability, however, these dyes were not very effective in determining 
damage due to the color of the dye being similar to lysed red blood cells and because the 
dyes were not stable enough to maintain detectable levels in the blood stream. Azo dyes 
such as Trypan Blue and Evans Blue were also used as these dyes are relatively stable in the 
blood due to their ability to bind proteins in the serum and plasma and because lower 
concentrations of the dyes were sufficient to detect a permeable BBB (Bladin, 2014). Evans 
Blue has remained a widely used dye to assess BBB damage despite the major drawback 
that there is free unbound Evans Blue even at low concentrations. Unbound Evans Blue 
readily diffuses across an intact BBB and is known to bind to brain tissue and can contribute 
to false positive results or high background (Saunders et al., 2015).
A better alternative to Evans Blue and other molecules for assessing BBB permeability are 
dextrans labeled with biotin or fluorophores. Dextrans are made up of varying chain lengths 
of glucose ranging from 4 – 70 kDa. These molecules have high stability and sensitivity and 
can be utilized for ascertaining the degree of damage to the BBB (Ek et al., 2006; Ek et al., 
2001). In addition, since these molecules are not endogenous and cannot be confused with 
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endogenous molecules, they can be introduced at various times throughout the life cycle of a 
disease in order to determine the time of BBB disruption and in turn, information regarding 
causality.
Critical Parameters
1. It is important to use a correct dose of ketamine/xylazine cocktail for anesthesia. 
The dose should be sufficient for the rat to remain at a surgical plane of 
anesthesia without being lethal. For good perfusion to occur the heart should be 
beating at regular intervals when the heparin is injected into the left ventricle. 
The heparin injection is given in order to prevent platelet aggregation within the 
blood vessels and to provide a free flow of blood without any back pressure 
during perfusion, thereby minimizing rupture of small blood vessels and 
capillaries.
2. The flow of the perfusion solution needs to be maintained at a rate that is not too 
high as it would increase pressure on small capillaries causing them to rupture. 
On the other hand pressure has to be maintained sufficiently to perfuse the 
smallest diameter capillaries.
3. The incision made in the right atrium for blood outflow has to be sufficiently 
large (~0.5 cm) for the blood to empty freely without building back pressure.
4. The concentration of FITC-dextran solution used in perfusion should be high 
enough to overcome the dilution by blood in the vessels during perfusion. The 
optimal concentration of FITC-dextran to use in perfusion should be empirically 
determined by the experimenter based on the weight of the animal.
5. It is important to ensure that FITC-dextran powder is completely solubilized 
prior to perfusion and is cold.
6. Rats must be decapitated and the brain removed immediately after perfusion with 
FITC-dextran is completed. This would minimize artificial leakage of FITC-
dextran from the vessels in the absence of active perfusion by the pump.
7. Cryoprotection of the brain is essential for preventing sudden osmotic changes in 
cells during flash freezing that would burst the cell wall, damage tissue, and 
contribute to artificial leakage of FITC-dextran.
8. Do not immerse brains in 2-methylbutane for longer than 5 min as it causes 
fracturing of the tissue.
9. Using subbed slides for mounting tissue sections helps the tissue adhere to and 
flatten on the glass slide. Additionally, it prevents the sections from lifting off the 
slide when incubating in DRAQ5.
10. It is essential to equilibrate the brains to the temperature of the cryostat for at 
least 2 hr. Frequently, the outside of the brain is at a different temperature 
compared to the inner regions and this interferes with obtaining consistent slice 
thickness and also affects the quality of the section.
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11. The temperature at which the sections are sliced is important. Sectioning when it 
is too warm will make the tissue clump and stick to itself. In contrast, if the 
cryostat temperature is too cold, the tissue will crack and roll up tightly and 
make it difficult to unroll without causing damage to the tissue. Appropriate 
temperature setting of the cryostat depends on ambient temperature and 
humidity, and should be determined prior to sectioning of the area of interest by 
assessing the quality of sections from a region of the brain that is not of interest.
12. After sectioning, the tissue slices should be carefully and gently transferred from 
the cryostat blade using a thin brush and placed on the slide, as the blood vessels 
can break due to mechanical agitation and FITC can leak out of the capillaries.
13. Low-light conditions should be maintained when working with the FITC-dextran 
perfused brain tissue to minimize the degradation of fluorescence due to 
quenching by ambient bright light. Low ambient light and covering the brains 
and tissue with foil help maintain fluorescence.
14. Slide mounted tissue sections need to be completely rehydrated in PBS (with or 
without DRAQ5) prior to Fluoromount-G application and coverslipping. 
Fluoromount-G is a mounting media that works well on wet tissue but its 
application to dry dehydrated sections forms numerous small air bubbles during 
setting of the mounting media.
15. Do not wash the section after incubation with DRAQ5 as it could wash out 
FITC-dextran and decrease the DRAQ5 signal making it difficult to identify the 
correct focal plane during imaging.
16. Both control and treated groups need to be imaged in every session. This would 
take into account any day-to-day variability or unintended changes in the 
confocal microscope and treatment of the slides.
17. Same brain areas/regions should be imaged in control and experimental groups 
in one imaging session rather than imaging all the brain regions of one group 
followed by a different group.
18. Once the imaging parameters are established, the investigator performing the 
analyses should be blind to the treatment conditions in order to eliminate 
introduction of bias to imaging measures.
Troubleshooting
1. Too dark or no visible capillaries in a control rat can be due to poor perfusion
a. Liver clearing can be used as an indicator of perfusion. The liver should 
begin to clear out in 5 – 10 s after starting perfusion. If this does not 
happen, readjust the position of the 16 G needle in the ventricle making 
sure that the beveled tip is not against the wall of the heart or septum.
b. Increase the volume of FITC-dextran perfused. The amount of FITC-
dextran suggested (12 mL) is for rats weighing between 250–300 g. 
Natarajan et al. Page 14
Curr Protoc Neurosci. Author manuscript; available in PMC 2018 April 10.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Heavier rats may require a greater volume of perfused FITC-dextran to 
fill the small capillaries in the brain.
c. An increase in the pump flow rate could also be tried, however there is 
a concern that higher speeds and therefore, higher pressure, could cause 
brain capillaries to rupture and leak FITC-dextran, leading to false 
positives for BBB disruption. Keep the pump rate consistent for all 
control and experimental groups so that changes in the rate of the pump 
do not unintentionally cause variability in BBB disruption.
2. Bright fluorescent speckles all over the section and slides during imaging
a. Too much disruption of the tissue section when slicing or placing onto 
subbed slides can rupture blood vessels and capillaries causing FITC-
dextran to leak out.
b. Kimwipes or other lab tissues can leave behind specks and debris that 
fluoresce at different wavelengths of light and should not be used for 
cleaning slides. A soft microfiber cloth is a better alternative for wiping 
slides clean.
c. The freezing process could also lead to bright fluorescent specks over 
the tissue. Incubation in the 2-methylbutane for longer than 5 min could 
cause tissue dehydration and rupture of cell membranes.
Statistical Analyses
Statistical analysis software
1. Any statistical analysis software can be used.
2. The appropriate analysis to be conducted should be determined based on the 
experimental design for comparisons between treated and untreated groups. For 
example, in order to determine whether BBB permeability is increased in 
methamphetamine treated rats compared to saline, a t-test can be carried out. 
Further details on how to process data from images of FITC-dextran 
extravasation within the brain is provided below in the “Image Analysis” section.
Image Analysis—Start Image J software and open the raw confocal image file of interest.
Remove Brightly Stained Capillaries
1. Make a projected image using the option on the top menu. Select Image → 
Stacks → Z project
2. Select Process → Noise → Remove outlier
3. Select Bright Outliers
4. Set Radius and Threshold to remove capillary staining in control image
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5. A starting point for adjusting and removing the capillaries can be setting Radius: 
20 px and Threshold: 30 px. Adjust these values until the capillaries are fully 
eliminated in the image (Figure 4B and D).
6. Keep settings the same for all images that will be compared with one another. 
For all the settings for images from the cortex of different treatment groups of 
animals should be kept the same; however, the settings for images of the 
hippocampus can be different from those of the cortex.
Measure the fluorescence of the entire image without capillary staining
1. Select Analyze from the top menu → Measure
2. A box will pop up on the right of the screen with numbers. Copy all the values 
into an Excel spreadsheet, making note of the rat and image number.
3. Use the “mean” value that is provided to perform calculations.
Example Analysis for Images from Rats Treated with Saline or Methamphetamine
• A total of 4 rats were used for the purpose of this example - 2 rats treated with 
saline and 2 with methamphetamine. Three images were taken from 3 separate 
sections of the cortex for each rat using a confocal microscope. Projection 
images were analyzed using ImageJ and example analysis is presented in Figure 
5.
• As mentioned above, the Radius and Threshold were set to 20 px and 30 px, 
respectively, in all images, to remove bright outliers (Figure 4).
• The remaining fluorescence was measured, as described above, and the mean 
values for each image were recorded, in the “The ImageJ Mean Measure of 
Individual Images” column, for example.
• The mean fluorescence of each of the individual images was calculated for each 
rat, as seen in the “The Mean of the ImageJ Measures” column.
• The mean fluorescence of all Saline treated rats was calculated, and presented in 
the “Mean of all Saline Treated Rats” column.
• The mean fluorescence of each rat was calculated as a percentage of the Saline 
treated rats, as indicated in the “Percent of Saline Treated Rats” column.
• The mean and standard error was then calculated for each treatment group, 
Saline and Methamphetamine, from the “Percent of Saline Treated Rats” values, 
and are presented in the “Mean Percent of Saline Treated Rats” and “Standard 
Error” columns, respectively.
• When the number of rats is appropriate for statistical analysis, a t-test could be 
used to determine whether there is a significant difference in extravagated 
fluorescence between the 2 treatment groups, Saline and Methamphetamine.
Understanding Results
The following observations are possible:
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1. Bright distinct capillaries on a dark background - Distinct fluorescent capillaries 
filled with FITC-dextran on a dark background indicates intact BBB (Figure 2A).
2. Bright distinct capillaries on a light background - This indicates either that the 
capillaries are fairly intact but have increased permeability or that the capillaries 
have ruptured anytime during perfusion, freezing, sectioning, or mounting tissue 
on slides and are leaking FITC-dextran into the brain parenchyma (Figure 2B). 
There is a possibility that the capillaries will be also be wider in this case, 
indicating diffusion of the FITC-dextran outside of the capillary and remaining 
within the perivascular space.
3. Faint capillaries on a dark background. This is likely due to poor perfusion of the 
capillaries caused by clots in the blood vessels or rupture of blood vessels during 
transcardial perfusion (Figure 3).
4. Faint capillaries on a light background could indicate that the capillaries are not 
intact, have high permeability and could not contain the FITC-dextran, i.e. all of 
the FITC-dextran has leaked out of the capillaries.
Time Considerations
The preparations of solutions for perfusion, fixation and cryoprotection can take up to 4 hrs. 
The procedure for subbing slides can take around 5hrs – overnight, including preparation of 
the subbing solution, slides and for applying multiple layers of gelatin treatment onto the 
slides. Perfusion, decapitation and whole brain extraction takes approximately 10 min per 
rat. Once the brain is extracted, it is placed in 4% PFA at 4°C for 3 days, followed by serial 
overnight immersion in 10% and 20% glycerol for cryoprotection. Cooling down the 2-
methylbutane solution for freezing the brain can take between 2–4 hrs and freezing the brain 
takes 5 min per brain. Mounting and equilibrating the brain to cryostat temperature take 
approximately 3 hrs. The time taken for sectioning each brain depends on the region/s of 
interest and can take several hours. Once the sections are placed and spread with a drop of 
water on the slides, air drying the section to help adhere them to the slides takes about 30 
min. DRAQ5 nuclei staining of slides takes approximately 10 min and coverslips are set 
overnight after applying the mounting media on the sections. Imaging the tissue sections can 
take anywhere from several hours to days depending on the region/s of interest and number 
of slides to image. Once the images are captured, data manipulation and analysis takes 
around 15 min per image.
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Significance Statement
Increased permeability of the blood-brain barrier (BBB) can often lead to detrimental 
consequences, including neuropathology, when harmful agents that normally do not cross 
into the brain from the circulatory system can access the brain. On the other hand, it may 
be desirable to increase the permeability of the BBB to deliver therapeutic agents that 
normally cannot cross the BBB. Hence, a reliable method is needed to assess the integrity 
of the BBB. The peripheral perfusion of a large fluorescently labeled molecule that does 
not normally penetrate the BBB, such as fluorescein isothiocyanate (FITC) labeled 
dextran, and its measurement in the brain would be a sensitive indicator of a possible 
disruption of the BBB.
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Figure 1. 
Perfusion setup and surgery. A) Tools required for perfusion. B) Perfusion setup showing 
FITC-dextran solution in a graduated cylinder wrapped in foil. The inflow tube of the 
peristaltic perfusion pump is placed in the FITC-dextran solution and the outflow tube is 
attached to a 19 G needle that is inserted into the left ventricle. C) Image of a rat ready for 
perfusion with FITC-dextran. Arrow denotes the location where the needle will be inserted 
in the left ventricle. Note the dark coloration of the liver prior to starting perfusion. D) 
Image of a rat after perfusion. Note the lighter color of the liver. E) Image of brain prior to 
removal from the cranium. Note the absence of pink coloration of the brain due to perfusion 
of the blood vessels.
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Figure 2. 
Cortical capillaries after FITC-dextran perfusion. A) FITC-dextran extravasation in a control 
animal. Image shows capillaries filled with brightly fluorescent FITC-dextran on a dark 
background indicative of uncompromised BBB. B) Cortical capillaries after FITC-dextran 
perfusion in a rat treated with methamphetamine demonstrating a permeable BBB. Image 
shows capillaries filled with brightly fluorescent FITC-dextran on a bright green background 
indicative of extravasation of FITC-dextran beyond the BBB.
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Figure 3. 
Poor FITC-dextran perfusion of cortical capillaries. Image shows capillaries that are sparsely 
filled with FITC-dextran.
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Figure 4. 
Image manipulation to remove cortical capillaries after FITC-dextran perfusion. A) FITC-
dextran extravasation in an animal with uncompromised capillaries showing brightly 
fluorescent FITC dextran filled capillaries on dark background. B) Cortical capillary 
fluorescence removed from the image presented in panel A using Image J software to 
visualize FITC dextran extravasation into the brain parenchyma in a BBB intact rat. C) 
FITC-dextran extravasation in an animal with compromised capillaries showing brightly 
fluorescent FITC-dextran filled capillaries on a bright background. D) Cortical capillary 
fluorescence removed from the image presented in panel C using Image J software to 
visualize FITC-dextran extravasation into the brain parenchyma in a rat with a permeabilized 
BBB.
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Figure 5. 
Example analysis of images from Saline and Methamphetamine treated rats. For the purpose 
of this example, a total of 4 rats were used, 2 saline treated and 2 methamphetamine treated. 
Three images were taken from 3 separate brain sections of the cortex. The individual mean 
fluorescent values for each image, after removal of the bright outliers, are listed for each 
image for each rat. Additional values are also presented, indicating the calculations made to 
arrive at the final presentation of the data, which was the average fluorescence for each 
treatment group as a percent of the controls (Saline).
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